Axalbion Therapeutics Limited

Axalbion Therapeutics Limited is a British pharmaceutical company developing TRPM8 agonists to treat chronic cough and dry eyes, headquartered in the United Kingdom.

Here are key aspects of the company:

• Products & Services: The company has synthesized and examined new TRPM8 agonists, identifying its lead candidate AX-8 for therapeutic use.
• Industries: Axalbion focuses on treating chronic cough and dry eyes, which are described as common and debilitating disorders with limited treatment options.
• Innovation: Their molecule AX-8 features a rapid onset of action that normalizes abnormal cough and lacrimation reflexes while decreasing sensory discomfort through innovative topical treatments.

Axalbion Therapeutics Limited is advancing its lead compound AX-8 to the clinical stage specifically for the management of chronic cough.